Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
29.68
+0.34 (1.16%)
Nov 19, 2024, 4:00 PM EST - Market closed
Dyne Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Dyne Therapeutics stock have an average target of 52.44, with a low estimate of 35 and a high estimate of 66. The average target predicts an increase of 76.68% from the current stock price of 29.68.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DYN stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $50 | Strong Buy | Maintains | $50 | +68.46% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +85.31% | Nov 13, 2024 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $43 → $35 | Buy → Hold | Downgrades | $43 → $35 | +17.92% | Oct 24, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $53 | Buy | Reiterates | $53 | +78.57% | Sep 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +85.31% | Sep 4, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
549.88K
EPS This Year
-3.03
from -3.95
EPS Next Year
-3.19
from -3.03
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 5.1M | 32.2M | ||
| Avg | n/a | 549,884 | 10.9M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 5,762.0% | ||
| Avg | - | - | 1,885.0% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.89 | -2.69 | -3.02 | ||
| Avg | -3.03 | -3.19 | -3.22 | ||
| Low | -3.22 | -3.42 | -3.42 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.